C1orf51 Activators encompass a range of chemical compounds that facilitate the enhancement of C1orf51's functional activity through distinct signaling pathways and molecular interactions. Forskolin and 8-Br-cAMP promote the activation of protein kinase A (PKA) by increasing intracellular cAMP levels, which can lead to phosphorylation events that enhance C1orf51 activity. IBMX, by inhibiting cAMP degradation, potentially maintains PKA activation, indirectly supporting C1orf51's functions. PMA's activation of PKC and Ionomycin's elevation of intracellular calcium levels both initiate signaling cascades that could phosphorylate or otherwise modulate proteins that interact with C1orf51, thereby enhancing its activity. Calyculin A and Okadaic acid, through inhibition of protein phosphatases, prevent the dephosphorylation of proteins within C1orf51's regulatory network, which is likely to result in its functional upregulation. Additionally, Epigallocatechin gallate (EGCG) may block kinase activities that, when inhibited, lead to a net positive effect on C1orf51's role.
Furthermore, Sphingosine-1-phosphate (S1P) through its receptor-mediated signaling, may activate downstream molecules that interact with C1orf51, enhancing its activity within its specific pathway. LY294002's inhibition of the PI3K/AKT pathway can create a cellular environment that indirectly leads to the upregulation of C1orf51's function due to the complex interplay of signaling networks. Staurosporine, although a general kinase inhibitor, may selectively affect pathways that augment C1orf51's activity by the nuanced balance of kinase and phosphatase actions. Lastly, Thapsigargin raises cytosolic calcium levels, activating calcium-dependent proteins that could serve to enhance C1orf51's activity through calcium signaling pathways. Each of these activators, through their unique and specific effects on cellular signaling, contributes to the potentiation of C1orf51 without necessitating a rise in its expression or direct activation, highlighting the intricate web of cellular regulation that governs protein functionality.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX (3-Isobutyl-1-methylxanthine) is a non-selective inhibitor of phosphodiesterases, enzymes that degrade cAMP and cGMP. By preventing cAMP degradation, IBMX can indirectly enhance the signaling pathways that involve cAMP, potentially enhancing the functional activity of C1orf51 through cAMP-dependent processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC plays a role in various signaling pathways and could phosphorylate proteins that interact with C1orf51, potentially enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. Elevated calcium can activate calcium-dependent signaling pathways, which may include proteins that modulate the activity of C1orf51. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates cAMP-dependent pathways, such as PKA. By doing so, it may enhance the functional activity of C1orf51 through cAMP-responsive elements and associated proteins. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of cellular proteins. This can modify signaling pathways and potentially enhance the activity of C1orf51 by preventing dephosphorylation of proteins involved in its regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit a variety of kinases. By altering the phosphorylation status of proteins in related pathways, EGCG could lead to an enhanced functional activity of C1orf51 by affecting proteins that regulate its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors and is involved in various signaling pathways. This activation can lead to downstream effects that may enhance the functional activity of C1orf51 through lipid signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of serine/threonine protein phosphatases. This inhibition can lead to increased phosphorylation within cells, potentially enhancing the activity of C1orf51 by affecting proteins that regulate its activity. | ||||||